Market Cap (In INR)
417.8 Billion
Revenue (In INR)
147.55 Billion
Net Income (In INR)
10.22 Billion
Avg. Volume
205.36 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 239.45-395.65
- PE
- -
- EPS
- -
- Beta Value
- 0.464
- ISIN
- INE376G01013
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Siddharth Mittal BCom, CA, CPA
- Employee Count
- -
- Website
- https://www.biocon.com
- Ipo Date
- Details
- Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, the company is involved in the integrated discovery, development, and manufacturing services for small and large molecules. It serves customers in approximately 120 countries. The company was incorporated in 1978 and is headquartered in Bengaluru, India.
More Stocks
-
0JSPLTC Properties, Inc.
0JSP
-
NTRBWNutriband Inc.
NTRBW
-
HOFBFHofseth BioCare ASA
HOFBF
-
ELRXFAB Electrolux (publ)
ELRXF
-
8273Izumi Co., Ltd.
8273
-
PALIPalisade Bio, Inc.
PALI
-
CACO
-
016610